Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action
- PMID: 32445522
- DOI: 10.1111/apt.15700
Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action
Comment in
-
Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply.Aliment Pharmacol Ther. 2020 Jun;51(12):1430-1432. doi: 10.1111/apt.15718. Aliment Pharmacol Ther. 2020. PMID: 32445526 No abstract available.
Comment on
-
Modelling NAFLD disease burden in four Asian regions-2019-2030.Aliment Pharmacol Ther. 2020 Apr;51(8):801-811. doi: 10.1111/apt.15673. Epub 2020 Mar 4. Aliment Pharmacol Ther. 2020. PMID: 32133676 Free PMC article.
References
REFERENCES
-
- Younossi ZM, Blissett D, Blissett R, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64:1577-1586.
-
- Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol. 2019;70:531-544.
-
- Estes C, Chan HLY, Chien RN, et al. Modelling NAFLD disease burden in four Asian regions-2019-2030. Aliment Pharmacol Ther. 2020;51:801-811
-
- Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol. 2018;69:896-904.
-
- NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet;2017;390:2627-2642.
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous